LISAvienna: It’s time to review the latest life sciences news from Vienna

The life sciences community in Vienna came up with loads of interesting news in the last weeks. Some of them are presented in the latest edition of our e-newsletter.

Learn more about the last weeks‘ top stories, upcoming events and funding opportunities in our 06-2015 e-newsletter edition. This time we feature for example AFFiRiS’ new financing round, the new team of Vice Rectors at the Medical University of Vienna, Scarletred acquiring a phase II product from Apeiron and Valneva taking direct control over marketing and distribution of IXIARO®.

Register here to stay updated on a regular base. Our e-newsletter is published 10 times a year.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)